Unknown

Dataset Information

0

Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened.


ABSTRACT: Inhibitors of the Hedgehog signaling pathway have generated a great deal of interest in the oncology area due to the mounting evidence of their potential to provide promising therapeutic options for patients. Herein, we describe the discovery strategy to overcome the issues inherent in lead structure 1 that resulted in the identification of Smoothened inhibitor 1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea (PF-04449913, 26), which has been advanced to human clinical studies.

SUBMITTER: Munchhof MJ 

PROVIDER: S-EPMC4025788 | BioStudies | 2012-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC5342419 | BioStudies
2019-01-01 | S-EPMC6850403 | BioStudies
2017-01-01 | S-EPMC5543507 | BioStudies
1000-01-01 | S-EPMC4018168 | BioStudies
1000-01-01 | S-EPMC4007836 | BioStudies
2011-01-01 | S-EPMC4018057 | BioStudies
2011-01-01 | S-EPMC3109749 | BioStudies
1000-01-01 | S-EPMC4007909 | BioStudies
1000-01-01 | S-EPMC4360146 | BioStudies
2018-01-01 | S-EPMC6219857 | BioStudies